The Future of Medicine

Developing New Categories of Medicine

Our goal is to improve and extend the lives of patients through the development of breakthrough medicine

Exploring the Brain Immune Gut (BIG) Axis

PureTech Health is pioneering the development of therapeutics based on the crosstalk and biology of the Brain-Immune-Gut Axis

Giving Life to Science

Our goal is to improve and extend the lives of patients

The biopharma company of the future

Discovery Reinvented

Publications -2018-03-23
PureTech's Lymphatic Leap
Publications -2017-09-19
Gamma Delta T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation

CD4(+) T regulatory cells (T(regs)), which express the Foxp3 transcription factor, play a critical role in the maintenance of immune homeostasis. Here, we show that in mice, T(regs) were most abundant in the colonic mucosa.

Full Article

Publications -2017-09-19
Science: The Gut’s Clostridium Cocktail
Press releases
PureTech’s Vedanta Biosciences Announces Initiation of a Phase 2 Study for Lead Product Candidate, VE303


PureTech’s Chief of Research and Strategy Eric Elenko to participate in plenary panel debate, “Is Convergence Driving Investment Syndicates?” at Genesis 2018 in London on December 13, 2018
Press releases
Bristol-Myers Squibb and PureTech’s Vedanta Biosciences Announce New Immuno-Oncology Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers